FDA Grants Supplemental Indication Approvals to Three Amyloid PET Imaging Agents, Expanding the Role
July 02, 2025
July 02, 2025
RESTON, Virginia, July 2 [Category: Medical] -- The Society of Nuclear Medicine and Molecular Imaging issued the following news release:
* * *
FDA Grants Supplemental Indication Approvals to Three Amyloid PET Imaging Agents, Expanding the Role of Nuclear Medicine in Neurology
SNMMI commends the U.S. Food and Drug Administration (FDA) for recognizing the critical role of nuclear medicine in Alzheimer's and dementia imaging and therapy.
On J . . .
* * *
FDA Grants Supplemental Indication Approvals to Three Amyloid PET Imaging Agents, Expanding the Role of Nuclear Medicine in Neurology
SNMMI commends the U.S. Food and Drug Administration (FDA) for recognizing the critical role of nuclear medicine in Alzheimer's and dementia imaging and therapy.
On J . . .